Pneumococcal vaccine in rheumatoid arthritis

Decreased response while taking methotrexate

James Robert O'Dell, Joseph Gilg, William Palmer, Claire Haire, Lynell Warren Klassen, Gerald Francis Moore

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

To determine the ability of patients with rheumatoid arthritis to respond to pneumococcal vaccination and whether age or methotrexate affects this response, we studied 40 patients with rheumatoid arthritis who received pneumococcal vaccination. Patients were equally divided into four groups according to age and whether or not they were taking methotrexate. Pneumococcal antibody levels were drawn prevaccination and 6 weeks postvaccination. Eighty percent of rheumatoid arthritis patients vaccinated achieved protective levels of antibodies. The age of the patient did not affect this response, but methotrexate-treated patients responded less well than those not taking methotrexate (p = 0.03). In general, patients with rheumatoid arthritis respond well to the pneumococcal vaccine. Pneumococcal vaccination of rheumatoid arthritis patients before initiating methotrexate therapy is strongly recommended.

Original languageEnglish (US)
Pages (from-to)59-63
Number of pages5
JournalJournal of Clinical Rheumatology
Volume2
Issue number2
StatePublished - Apr 1 1996

Fingerprint

Pneumococcal Vaccines
Methotrexate
Rheumatoid Arthritis
Vaccination
Antibodies

Keywords

  • Methotrexate
  • Pneumococcal vaccination
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Pneumococcal vaccine in rheumatoid arthritis : Decreased response while taking methotrexate. / O'Dell, James Robert; Gilg, Joseph; Palmer, William; Haire, Claire; Klassen, Lynell Warren; Moore, Gerald Francis.

In: Journal of Clinical Rheumatology, Vol. 2, No. 2, 01.04.1996, p. 59-63.

Research output: Contribution to journalArticle

@article{4d1293afc9324bcb89a4d01f9c54f4b7,
title = "Pneumococcal vaccine in rheumatoid arthritis: Decreased response while taking methotrexate",
abstract = "To determine the ability of patients with rheumatoid arthritis to respond to pneumococcal vaccination and whether age or methotrexate affects this response, we studied 40 patients with rheumatoid arthritis who received pneumococcal vaccination. Patients were equally divided into four groups according to age and whether or not they were taking methotrexate. Pneumococcal antibody levels were drawn prevaccination and 6 weeks postvaccination. Eighty percent of rheumatoid arthritis patients vaccinated achieved protective levels of antibodies. The age of the patient did not affect this response, but methotrexate-treated patients responded less well than those not taking methotrexate (p = 0.03). In general, patients with rheumatoid arthritis respond well to the pneumococcal vaccine. Pneumococcal vaccination of rheumatoid arthritis patients before initiating methotrexate therapy is strongly recommended.",
keywords = "Methotrexate, Pneumococcal vaccination, Rheumatoid arthritis",
author = "O'Dell, {James Robert} and Joseph Gilg and William Palmer and Claire Haire and Klassen, {Lynell Warren} and Moore, {Gerald Francis}",
year = "1996",
month = "4",
day = "1",
language = "English (US)",
volume = "2",
pages = "59--63",
journal = "Journal of Clinical Rheumatology",
issn = "1076-1608",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Pneumococcal vaccine in rheumatoid arthritis

T2 - Decreased response while taking methotrexate

AU - O'Dell, James Robert

AU - Gilg, Joseph

AU - Palmer, William

AU - Haire, Claire

AU - Klassen, Lynell Warren

AU - Moore, Gerald Francis

PY - 1996/4/1

Y1 - 1996/4/1

N2 - To determine the ability of patients with rheumatoid arthritis to respond to pneumococcal vaccination and whether age or methotrexate affects this response, we studied 40 patients with rheumatoid arthritis who received pneumococcal vaccination. Patients were equally divided into four groups according to age and whether or not they were taking methotrexate. Pneumococcal antibody levels were drawn prevaccination and 6 weeks postvaccination. Eighty percent of rheumatoid arthritis patients vaccinated achieved protective levels of antibodies. The age of the patient did not affect this response, but methotrexate-treated patients responded less well than those not taking methotrexate (p = 0.03). In general, patients with rheumatoid arthritis respond well to the pneumococcal vaccine. Pneumococcal vaccination of rheumatoid arthritis patients before initiating methotrexate therapy is strongly recommended.

AB - To determine the ability of patients with rheumatoid arthritis to respond to pneumococcal vaccination and whether age or methotrexate affects this response, we studied 40 patients with rheumatoid arthritis who received pneumococcal vaccination. Patients were equally divided into four groups according to age and whether or not they were taking methotrexate. Pneumococcal antibody levels were drawn prevaccination and 6 weeks postvaccination. Eighty percent of rheumatoid arthritis patients vaccinated achieved protective levels of antibodies. The age of the patient did not affect this response, but methotrexate-treated patients responded less well than those not taking methotrexate (p = 0.03). In general, patients with rheumatoid arthritis respond well to the pneumococcal vaccine. Pneumococcal vaccination of rheumatoid arthritis patients before initiating methotrexate therapy is strongly recommended.

KW - Methotrexate

KW - Pneumococcal vaccination

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0030004324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030004324&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 59

EP - 63

JO - Journal of Clinical Rheumatology

JF - Journal of Clinical Rheumatology

SN - 1076-1608

IS - 2

ER -